Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Radiographic and the Esthetic Outcome of Two Different Bone Grafting Techniques in Early Implant Placement

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03302143
Recruitment Status : Completed
First Posted : October 4, 2017
Last Update Posted : October 4, 2017
Sponsor:
Information provided by (Responsible Party):
The University of Texas Health Science Center at San Antonio

Brief Summary:

Total of 48 subjects were randomly assigned to treatment groups:

UT Health Science Center at San Antonio Chi Mei Medical Center, Tainan, Taiwan

Patients require a maxillary non-molar extraction site that is planned to be replaced by a dental implant and crown. This includes Straumann BL SLActive: Narrow (3.3mm) & Regular (4.1mm) Crossfit implants in all available lengths.

Patients were randomly selected to receive either FDBA (test) or Autogenous bone + DBBM (control/standard) for contour augmentation.


Condition or disease Intervention/treatment Phase
Missing Tooth Fractured Tooth Procedure: Guided bone regeneration with Bovine Bone Mineral Procedure: Guided bone regeneration with freeze dried bone allograft Not Applicable

Detailed Description:

This comparative, randomized, prospective clinical study is designed to compare clinical outcomes and facial bone height and thickness of two different bone grafting techniques after augmentation in (Type 2) early implant placement.

Human subjects who could potentially qualify with the said inclusion criteria will be evaluated and screened. 24 human subjects who qualify for the procedure will have a thorough evaluation performed after obtaining consent from the patient. All subjects will require extraction of maxillary teeth (incisors, canines, premolars), followed by early implant placement of the missing teeth after 4 to 8 weeks extraction.

There will be two subject groups in this study in which the 24 human subjects in will randomly be placed by selecting the number "1" or "2" from a hat. 24 human subjects will be divided into two groups including 12 subjects using control group design and 12 subjects using test group design. 12 subjects will be placed randomly into Group 1 and will undergo the flapless extraction and early implant placement with GBR procedure using the control group design. 12 subjects will be placed randomly into Group 2 and will undergo the flapless extraction and early implant placement with GBR procedure using the test group design.

During the implant placement visit after 4 to 8 weeks of extraction, patient will be asked to select a number from a hat. If the number showed "1" as a control group, autograft , BBM and collagen membrane will be used as GBR materials after implant placement. If the number showed "2" as a test group, FDBA and collagen membrane will be used as GBR materials after implant placement.

Extraction sites will include maxillary teeth (11,12,13,14,15,21,22,23,24,25 according to FDI) having intact adjacent teeth. Implants placed for this study will have a SLActive surface, bone level design, Straumann NC 3.3mm or RC 4.1mm in diameter at all available implant lengths.

Control group: early implant placement with autograft plus BBM (Bio-Oss, Geistlich Pharm AG, Wolhausen, Switzerland) plus two layers of collagen membrane (BioGide®).

Test group: early implant placement with FDBA (Straumann Allograft GC®) plus two layers of collagen membrane (BioGide®).

These procedures will follow the guidelines as described by Buser et al. (2008). Implant placements will follow standard protocols utilizing tapping and placement with the hand ratchet.

A CBCT radiograph will be made during the screening visit to determine eligibility for the study and immediately following implant placement with GBR procedure to provide facial bone height and thickness measurements. The second CBCT procedure is not typically a standard of care procedure. After 12 months post loading healing time, the patient will receive another CBCT. This CBCT is also not a standard of care procedure but can accurately assess the amount of facial bone height and thickness maintained during the follow-up period.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 48 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: A comparative, randomized, prospective, clinical study
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Comparative, Randomized, Prospective, Clinical Study to Evaluate the Facial Bone and Esthetic Outcome of Buccal Augmentation Bone Grafting Techniques in Early (Type 2) Implant Placement
Actual Study Start Date : July 30, 2013
Actual Primary Completion Date : May 15, 2016
Actual Study Completion Date : May 15, 2016

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Control
Guided bone regeneration with Bovine Bone Mineral
Procedure: Guided bone regeneration with Bovine Bone Mineral
Guided bone regeneration with Bovine Bone Mineral

Experimental: Experimental
Guided bone regeneration with freeze dried bone allograft
Procedure: Guided bone regeneration with freeze dried bone allograft
Guided bone regeneration with freeze dried bone allograft




Primary Outcome Measures :
  1. Facial bone thickness [ Time Frame: Measured at 1 year post-loading ]
    Facial bone thickness 1 year post-loading at 1, 3, and 5mm from the implant platform


Secondary Outcome Measures :
  1. Change in facial bone thickness [ Time Frame: Between implant placement and 1 year post-loading ]
    Change in facial bone thickness between implant placement and 1 year post-loading

  2. mPI measurement [ Time Frame: Measured at 6 and 12-months post-loading ]
    Measurement of modified Plaque Index

  3. PD measurement [ Time Frame: Measured at 6 and 12-months post-loading ]
    Measurement of pocket depth

  4. mSBI measurement [ Time Frame: Measured at 6 and 12-months post-loading ]
    Measurement of modified sulcus bleeding index

  5. KM measurement [ Time Frame: Measured at 6 and 12-months post-loading ]
    Measurement of keratinized mucosa



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. The patient is 18 years or older.
  2. Non-smoker or patient has smoking habit and < 1 pack per day.
  3. Ability to understand and provide informed consent before starting the study.
  4. Ability and willingness to comply with all study requirements.
  5. The patient, if of child-bearing potential, has a negative urine pregnancy test.
  6. Adequate oral hygiene to allow for implant therapy consistent with standards of care.
  7. Adequate primary stability following early implant placement protocols utilizing Straumann Bone Level implants NC 3.3mm or RC 4.1mm in diameter at all available implant lengths.
  8. One or more teeth in maxilla (11,12,13,14,15,21,22,23,24,25 according to FDI) has been identified as having a hopeless prognosis requiring extraction leading to a single-tooth gap requiring implant placement as determined by clinician.
  9. Implant site that has a defect and requires bone augmentation. This will be determined by measuring on the CBCT image the available space for the implant and whether or not there is enough bone width where the implant is to be placed.

Exclusion Criteria:

  1. Patient reports current smoking habit > 1 pack per day or tobacco chewing use.
  2. History of alcoholism or drug abuse within the past 5 years.
  3. Severe bruxism or clenching habits.
  4. Patient has significant untreated periodontal disease (grade III or IV), caries, or clinical or radiographic signs of infection within two adjacent tooth positions of implant area.
  5. History of HIV infection, Hepatitis B or C.
  6. Patients with a history of systemic disease that precludes standard dental implant therapy.
  7. Presence of local inflammation or mucosal diseases such as lichen planus
  8. Patient history consistent with high risk for subacute bacterial endocarditis
  9. Current hematological disorder or coumadin (or similar) therapy
  10. Patient currently undergoing chemotherapy
  11. Patient history of radiation treatment to the head or neck
  12. Physical or mental handicaps that would interfere with patient's ability to exercise good oral hygiene on a regular basis
  13. Pregnant or breastfeeding women

Layout table for additonal information
Responsible Party: The University of Texas Health Science Center at San Antonio
ClinicalTrials.gov Identifier: NCT03302143     History of Changes
Other Study ID Numbers: HSC20120264H
First Posted: October 4, 2017    Key Record Dates
Last Update Posted: October 4, 2017
Last Verified: September 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: Yes

Keywords provided by The University of Texas Health Science Center at San Antonio:
Dental Implant
Guided Bone Regeneration
Contour Augmentation

Additional relevant MeSH terms:
Layout table for MeSH terms
Tooth Loss
Anodontia
Tooth Fractures
Periodontal Diseases
Mouth Diseases
Stomatognathic Diseases
Tooth Diseases
Tooth Abnormalities
Stomatognathic System Abnormalities
Congenital Abnormalities
Tooth Injuries
Wounds and Injuries